Biolamina
Microsoft Word - 2018-05 BL-NN-Duke_EN_Final.docx PRESS RELEASE Stockholm 16th of May 2018 BioLamina and Novo Nordisk partner to advance stem cell based therapies for three common medical conditions Stockhom, 16 May 2018 -- BioLamina and collaborators have partnered with Novo Nordisk A/S (Novo Nordisk), a Danish multinational pharmaceutical company, allowing Novo Nordisk to develop novel stem cell
https://www.regenerative-neurobiology.lu.se/sites/regenerative-neurobiology.lu.se/files/biolamina.pdf - 2026-07-19
